Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
| Brand name | LOSARTAN POTASSIUM |
| Generic name | LOSARTAN POTASSIUM |
| Active ingredient(s) | LOSARTAN POTASSIUM |
| Distributed by / for | Macleods Pharma Usa Inc |
| NDC | 33342-044-10 |
| Full product label | Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 |
| Recalling firm | Macleods Pharma Usa Inc |
| Distribution | Product was distributed nationwide. |
| Quantity | 12,408/90 count bottles; 1670/1000 count bottles =2,786,720 tablets |
| Recall initiated | 2022-04-15 |
| Report date | 2022-05-11 |
| Recall completed | 2023-10-13 |
| Recall number | D-0832-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗